EuBiologics

EuBiologics Co., Ltd., established in 2010 and based in Seoul, South Korea, is a biopharmaceutical company specializing in the development and supply of vaccines for epidemic prevention and antibiotic resistance. Its product portfolio includes Euvchol, an oral cholera prevention vaccine, and CRM197, a diphtheria toxin mutant vaccine. The company also offers customized services for mammalian and microbial cell-derived biopharmaceuticals, supporting clients from cell line development to GMP production, along with regulatory support. Additionally, EuBiologics provides contract testing services, process and formulation development, and licensing consulting services, contributing to human health across various stages of life.

Suk-keun Choi

CEO and Board Member

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.